title: Antiangiogenic therapy in patients with HER2-positive metastatic breast cancer: a case series.
authors.affiliation: Department of Medical Oncology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. Electronic address: olivia.le-saux@chu-lyon.fr.
authors.forename: Olivia
authors.initials: O
authors.lastname: Le Saux
authors.affiliation: Department of Medical Oncology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
authors.forename: Benoît
authors.initials: B
authors.lastname: You
authors.affiliation: Department of Medical Oncology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
authors.forename: Gilles
authors.initials: G
authors.lastname: Freyer
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000098:blood supply / Q000188:drug therapy* / Q000235:genetics; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases
keywords: Aflibercept; Bevacizumab; HER2-positive; Metastatic breast cancer